• Target：
• OLIG2

• Gene Name：
• olig2

• Human Gene Id：
• 10215

• Human Swiss Prot No：
• Q13516

• Mouse Swiss Prot No：
• Q9EQW6

• Immunogen：
• Synthesized peptide derived from human protein.AA range:1-100

• Specificity：
• This antibody detects endogenous levels of OLIG2 protein.

• Formulation：
• PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

• Source：
• Mouse, Monoclonal/IgG

• Dilution：
• WB 1:500-2000. IF 1:100-500. ELISA 1:1000-5000

• Purification：
• Protein G

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• Basic domain helix loop helix protein class B 1;Basic helix loop helix protein class B 1;BHLHB;bHLHB1;bHLHe19;Class B basic helix loop helix protein 1;Class B basic helix-loop-helix protein 1;class E basic helix loop helix protein 19;Class E basic helix-loop-helix protein 19;Human protein kinase C binding protein RACK17;Olig2;OLIG2_HUMAN;Oligo2;Oligodendrocyte lineage transcription factor 2;Oligodendrocyte specific bHLH transcription factor 2;Oligodendrocyte transcription factor 2;OTTHUMP00000067569;OTTHUMP00000067570;PRKCBP2;Protein kinase C binding protein 2;Protein kinase C binding protein RACK17;Protein kinase C-binding protein 2;Protein kinase C-binding protein RACK17;RACK17.

• Molecular Weight(Da)：
• 32kD

• Observed Band(KD)：
• 32kD

• Background：
• This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. [provided by RefSeq, Jul 2008],

• Function：
• disease:A chromosomal aberration involving OLIG2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(14;21)(q11.2;q22) with TCRA.,domain:The bHLH is essential for interaction with NKX2-2.,function:Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Cooperates with OLIG1 to establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development.,induction:By SHH. Also induced by NKX6-1 in the developing spinal cord, but not in the rostral hindbrain.,similarity:Contains 1 basic helix-loop-helix (bHLH) domain.,subcellular location:The NLS contained in the bHLH domain could be masked in the native form and translocation to the nucleus could be mediated by interaction either with class E bHLH par

• Subcellular Location：
• Nuclear

• Expression：
• Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable.

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs